Lessons Learned From Enhancing Vaccine Pharmacovigilance Activities During PsA-TT Introduction in African Countries, 2010–2013

Background. The rollout of the group A meningococcal vaccine, PsA-TT, in Africa's meningitis belt countries represented the first introduction of a vaccine specifically designed for this part of the world. During the first year alone, the number of people who received the vaccine through mass v...

Descripción completa

Detalles Bibliográficos
Autores principales: Diomandé, Fabien V. K., Yaméogo, Téné M., Vannice, Kirsten S., Preziosi, Marie-Pierre, Viviani, Simonetta, Ouandaogo, Claude-Roger, Keita, Modibo, Djingarey, Mamoudou H., Mbakuliyemo, Nehemie, Akanmori, Bartholomew Dicky, Sow, Samba O., Zuber, Patrick L. F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
The Meningitis Vaccine Project: The Development, Licensure, Introduction, and Impact of a New Group a Meningococcal Conjugate Vaccine for Africa
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639501/
https://www.ncbi.nlm.nih.gov/pubmed/26553675
http://dx.doi.org/10.1093/cid/civ599

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639501/
https://www.ncbi.nlm.nih.gov/pubmed/26553675
http://dx.doi.org/10.1093/cid/civ599

Ejemplares similares